<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"	"http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd"><html><head><meta http-equiv="content-type" content="text/html;charset=ISO-8859-1"><meta name="author" content="Marx Law Library, University of Cincinnati College of Law"><meta name="copyright" content="Copyright 1998-2004 University of Cincinnati, All Rights Reserved">	<title>Appendix F to Rule 15c3-1 -- Optional Market and Credit Risk Requirements for OTC Derivatives Dealers</title><meta name="keywords" content="securities, stocks, sec, law, regulation, compliance, securities and exchange commission, finance"><meta name="description" content="The Securities Lawyer's Deskbook contains the text of the basic federal securities laws and regulations."><meta name="rating" content="General"><meta name="revisit-after" content="7 days"><meta name="robots" content="all,index"><meta http-equiv="expires" content="0"><link rev="made" href="mailto:webmaster@law.uc.edu"><style type="text/css">A:link {color: red; text-decoration: none;  }A:active {color: red; text-decoration: none;  }A:hover {color: red; text-decoration: none;  }A:visited {color: red; text-decoration: none;  }.navbarright {font: bold 10pt Verdana, Ariel, Helvetica, san-serif; }.navbarbot {font: bold 10pt Verdana, Ariel, Helvetica, san-serif; }body{	scrollbar-highlight-color:#787878;	scrollbar-shadow-color:#4F4F4F;scrollbar-track-color:#000000;scrollbar-face-color: #FFFFFF;scrollbar-arrow-color:#FC1921;		scrollbar-darkshadow-color:#000000;	scrollbar-3dlight-color:#565652;	font-family: Verdana, Arial, Helvetica, sans-serif;	font-size: 9pt;	font-style: normal;	line-height: 1.5;	font-weight: normal;	background-color: #FFFFFF;	margin: 30px;}.main  { font-family: Verdana, Arial, Helvetica, sans-serif;	font-size: 9pt;	font-style: normal;	line-height: 1.5;	font-weight: normal;	background-color: #FFFFFF;	 }.small {    color: #000000;     font-family: Verdana, Tahoma, Arial, Helvetica, sans-serif;     font-size: 7pt;     font-weight: normal;     line-height: 1.5;     }.xsmall {    color: #000000;     font-family: Verdana, Tahoma, Arial, Helvetica, sans-serif;     font-size: 6pt;     font-weight: normal;     line-height: 1.5;     }</style></head><body>	<A NAME="top"></A><!-- Deskbook ID Start --><table width="100%" cellpadding=""3" cellspacing="0" border="0"><tr><td width="" align="left"><font size="6"  color="#000000" face="Courier New, Courier, mono"><strong>&nbsp;Securities Lawyer's Deskbook</strong></font><br /><font color="#FC1921" size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<em>publishedby</em> TheUniversityof Cincinnati College of Law</strong></font>	</td><td width="130" align="right">  <a href="../../index.html"><img src="../Images/uclawtag.gif" alt="UC Law logo" border="0" align="right"></a></td></tr></table><!-- Deskbook ID End --><!-- Update Information Start --><br><table align="right" width="200" class="navbarright" cellpadding="6" cellspacing="0"><tr><td align="right"><a href="#history">Regulatory History</a><br><br><a href="../xyz/search.html">Search Page</a><br><br><a href="../xyz/suggest.html">Suggestions</A><br><br><a href="../xyz/sldtoc.html">Main Table of Contents</A><br><br><a href="../index.html">Home</A></td></tr></table><!-- Update Information End --><!-- Folder Information Start --><DIV ALIGN=CENTER><br><H3><font color="#FC1921">General Rules and Regulations<br>promulgated<br>under the<br>Securities Exchange Act of 1934</FONT></H3></DIV><br><br><br><br><!-- Folder Information End --><!-- Item Title Start --><H3>Appendix F to Rule 15c3-1 -- Optional Market and Credit Risk Requirements for OTC Derivatives Dealers<HR></H3><!-- Item Title End --><br><CENTER><B>Application Requirements</B></CENTER><OL Type="a">	<LI type="a"><A NAME="a"></A>An OTC derivatives dealer may apply to the Commission	for authorization to compute capital charges for market and credit risk pursuant	to this Appendix F in lieu of computing securities haircuts pursuant to <a href="rule15c3-1.html#c.2.vi">Rule	15c3-1(c)(2)(vi)</A>.<br>	<br>		<OL Type="1">		<LI type="1"><A NAME="a.1"></A>An OTC derivatives dealer's application shall contain		the following information:<br>		<br>				<OL Type="i">			<LI type="i"><A NAME="a.1.i"></A>Executive summary. An OTC derivatives dealer shall			include in its application an Executive Summary of information provided to the Commission.<br>			<br>						<LI type="i"><A NAME="a.1.ii"></A>Description of methods for computing market risk			charges. An OTC derivatives dealer shall provide a description of all statistical			models used for pricing OTC derivative instruments and for computing value-at-risk			(&quot;VAR&quot;), a description of the applicant's controls over those models, and			a statement regarding whether the firm has developed its own internal VAR models.			If the OTC derivatives dealer's VAR model incorporates empirical correlations across			risk categories, the dealer shall describe its process for measuring correlations			and describe the qualitative and quantitative aspects of the model which at a minimum			must adhere to the criteria set forth in <a href="#e">paragraph (e)</A> of this Appendix			F. The application shall further state whether the OTC derivatives dealer intends			to use an alternative method for computing its market risk charge for equity instruments			and, if applicable, a description of how its own theoretical pricing model contains			the minimum pricing factors set forth in <a href="rule15c3-1a.html">Appendix A</A>.			The application shall also describe any category of securities having no ready market			or any category of debt securities which are below investment grade for which the			OTC derivatives dealer wishes to use its VAR model to calculate its market risk charge			or for which it wishes to use an alternative method for computing this charge and			a description of how those charges would be determined.<br>			<br>						<LI type="i"><A NAME="a.1.iii"></A>Internal risk management control systems. An OTC			derivatives dealer shall provide a comprehensive description of its internal risk			management control systems and how those systems adhere to the requirements set forth			in <a href="rule15c3-4.html#a">Rule 15c3-4(a)</A> through (d).<br>			<br>					</OL>		<LI type="1"><A NAME="a.2"></A>The Commission may approve the application after reviewing		the application to determine whether the OTC derivatives dealer:<br>		<br>				<OL Type="i">			<LI type="i"><A NAME="a.2.i"></A>Has adopted internal risk management control systems			that meet the requirements set forth in <a href="rule15c3-4.html">Rule 15c3-4</A>;			and<br>			<br>						<LI type="i"><A NAME="a.2.ii"></A>Has adopted a VAR model that meets the requirements			set forth in paragraphs <a href="#e.1">(e)(1)</A> and <a href="#e.2">(e)(2)</A> of			this Appendix F.<br>			<br>					</OL>		<LI type="1"><A NAME="a.3"></A>If the OTC derivatives dealer materially amends its		VAR model or internal risk management control systems as described in its application,		including any material change in the categories of non-marketable securities that		it wishes to include in its VAR model, the dealer shall file an application describing		the changes which must be approved by the Commission before the changes may be implemented.		After reviewing the application for changes to the dealer's VAR model or internal		risk management control systems to determine whether, with the changes, the OTC derivatives		dealer's VAR model and internal risk management control systems would meet the requirements		set forth in this Appendix F and Rule 15c3-4, the Commission may approve the application.<br>		<br>				<LI type="1"><A NAME="a.4"></A>The applications provided for in this paragraph (a)		shall be considered filed when received at the Commission's principal office in Washington,		DC. All applications filed pursuant to this paragraph (a) shall be deemed to be confidential.<br>		<br>		<br>			</OL>	<CENTER>	<B>Compliance With Rule 15c3-4</B></CENTER>	<P>	<LI type="a"><A NAME="b"></A>An OTC derivatives dealer must be in compliance in all	material respects with <a href="rule15c3-4.html">Rule 15c3-4</A> regarding its internal	risk management control systems in order to be in compliance with <a href="rule15c3-1.html">Rule	15c3-1</A>.	<P><CENTER>	<B>Market Risk</B></CENTER>	<P>	<LI type="a"><A NAME="c"></A>An OTC derivatives dealer electing to apply this Appendix	F shall compute a capital charge for market risk which shall be the aggregate of	the charges computed below:<br>	<br>		<OL Type="1">		<LI type="1"><A NAME="c.1"></A>Value-at-Risk. An OTC derivatives dealer shall deduct		from net worth an amount for market risk for eligible OTC derivative instruments		and other positions in its proprietary or other accounts equal to the VAR of these		positions obtained from its proprietary VAR model, multiplied by the appropriate		multiplication factor in <a href="#e.1.iv.C">paragraph (e)(1)(iv)(C)</A> of this		Appendix F. The OTC derivatives dealer may not elect to calculate its capital charges		under this paragraph (c)(1) until its application to use the VAR model has been approved		by the Commission.<br>		<br>				<LI type="1"><A NAME="c.2"></A>Alternative method for equities. An OTC derivatives		dealer may elect to use this alternative method to calculate its market risk for		equity instruments, including OTC options, upon approval by the Commission on application		by the dealer. Under this alternative method, the deduction for market risk must		be the amount computed pursuant to <a href="rule15c3-1a.html">Appendix A</A> to Rule		15c3-1. In this computation, the OTC derivatives dealer may use its own theoretical		pricing model provided that it contains the minimum pricing factors set forth in		Appendix A.<br>		<br>				<LI type="1"><A NAME="c.3"></A>Non-marketable securities. An OTC derivatives dealer		may not use a VAR model to determine a capital charge for any category of securities		having no ready market or any category of debt securities which are below investment		grade or any derivative instrument based on the value of these categories of securities,		unless the Commission has granted, pursuant to <a href="#a.1">paragraph (a)(1)</A>		of this Appendix F, its application to use its VAR model for any such category of		securities. The dealer in any event may apply, pursuant to paragraph (a)(1) of this		Appendix F, for an alternative treatment for any such category of securities, rather		than calculate the market risk capital charge for such category of securities under		<a href="rule15c3-1.html#c.2.vi">Rule 15c3-1(c)(2)(vi)</A> and <a href="rule15c3-1.html#c.2.vii">(vii)</A>.<br>		<br>				<LI type="1"><A NAME="c.4"></A>Residual positions. To the extent that a position		has not been included in the calculation of the market risk charge in paragraphs		(c)(1) through (c)(3) of this section, the market risk charge for the position shall		be computed under Rule 15c3-1(c)(2)(vi).<br>		<br>			</OL>	<CENTER>	<B>Credit Risk</B></CENTER>	<P>	<LI type="a"><A NAME="d"></A>The capital charge for credit risk arising from an OTC	derivatives dealer's transactions in eligible OTC derivative instruments shall be:<br>	<br>		<OL Type="1">		<LI type="1"><A NAME="d.1"></A>The net replacement value in the account of a counterparty		(including the effect of legally enforceable netting agreements and the application		of liquid collateral) that is insolvent, or in bankruptcy, or that has senior unsecured		long-term debt in default;<br>		<br>				<LI type="1"><A NAME="d.2"></A>As to a counterparty not otherwise described in paragraph		(d)(1) of this section, the net replacement value in the account of the counterparty		(including the effect of legally enforceable netting agreements and the application		of liquid collateral) multiplied by 8%, and further multiplied by the counterparty		factor. The counterparty factors are:<br>		<br>				<OL Type="i">			<LI type="i"><A NAME="d.2.i"></A>20% for counterparties with ratings for senior unsecured			long-term debt or commercial paper in the two highest rating categories by a nationally			recognized statistical rating organization (&quot;NRSRO&quot;);<br>			<br>						<LI type="i"><A NAME="d.2.ii"></A>50% for counterparties with ratings for senior			unsecured long-term debt in the third and fourth highest ratings categories by an			NRSRO; and<br>			<br>						<LI type="i"><A NAME="d.2.iii"></A>100% for counterparties with ratings for senior			unsecured long-term debt below the four highest rating categories; and<br>			<br>					</OL>		<LI type="1"><A NAME="d.3"></A>A concentration charge where the net replacement value		in the account of any one counterparty (other than a counterparty described in <a href="#d.1">paragraph (d)(1)</A> of this section) exceeds 25% of the OTC derivatives		dealer's tentative net capital, calculated as follows:<br>		<br>				<OL Type="i">			<LI type="i"><A NAME="d.3.i"></A>For counterparties with ratings for senior unsecured			long-term debt or commercial paper in the two highest rating categories by an NRSRO,			5% of the amount of the net replacement value in excess of 25% of the OTC derivatives			dealer's tentative net capital;<br>			<br>						<LI type="i"><A NAME="d.3.ii"></A>For counterparties with ratings for senior unsecured			long-term debt in the third and fourth highest rating categories by an NRSRO, 20%			of the amount of the net replacement value in excess of 25% of the OTC derivatives			dealer's tentative net capital; and<br>			<br>						<LI type="i"><A NAME="d.3.iii"></A>For counterparties with ratings for senior unsecured			long-term debt below the four highest rating categories, 50% of the amount of the			net replacement value in excess of 25% of the OTC derivatives dealer's tentative			net capital.<br>			<br>					</OL>		<LI type="1"><A NAME="d.4"></A>Counterparties that are not rated by an NRSRO may		be rated by the OTC derivatives dealer, or by an affiliated bank or affiliated broker-dealer		of the OTC derivatives dealer, upon approval by the Commission on application by		the OTC derivatives dealer. After reviewing the application to determine whether		the credit rating procedures and rating categories are equivalent to those used by		NRSROs and that such ratings are current, the Commission may approve the application.		The OTC derivatives dealer must make and keep current a record of the basis for the		credit rating for each counterparty. The record must be preserved for a period of		not less than three years, the first two years in an easily accessible place.<br>		<br>			</OL>	<CENTER>	<B>VAR Models</B></CENTER>	<P>	<LI type="i"><A NAME="e"></A>An OTC derivatives dealer's VAR model must meet the	following qualitative and quantitative requirements:<br>	<br>		<OL Type="1">		<LI type="1"><A NAME="e.1"></A>Qualitative requirements. An OTC derivatives dealerapplying		this Appendix F must have a VAR model that meets the following minimum qualitative		requirements:<br>		<br>				<OL Type="i">			<LI type="i"><A NAME="e.1.i"></A>The OTC derivatives dealer's VAR model must be integrated			into the firm's daily risk management process;<br>			<br>						<LI type="i"><A NAME="e.1.ii"></A>The OTC derivatives dealer must conduct appropriate			stress tests of the VAR model, and develop appropriate procedures to follow in response			to the results of such tests;<br>			<br>						<LI type="i"><A NAME="e.1.iii"></A>The OTC derivatives dealer must conduct periodic			reviews (which may be performed by internal audit staff) of its VAR model. The OTC			derivatives dealer's VAR model also must be subject to annual reviews conducted by			independent public accountants; and<br>			<br>						<LI type="i"><A NAME="e.1.iv"></A>The OTC derivatives dealer must conduct backtesting			of the VAR model pursuant to the following procedures:<br>			<br>						<OL Type="A">				<LI type="A"><A NAME="e.1.iv.A"></A>Beginning one year after the OTC derivatives				dealer begins using its VAR model to calculate its net capital, the OTC derivatives				dealer must conduct backtesting by comparing each of its most recent 250 business				days' actual net trading profit or loss with the corresponding daily VAR measures				generated for determining market risk capital charges and calibrated to a one-day				holding period and a 99 percent, one-tailed confidence level;<br>				<br>								<LI type="A"><A NAME="e.1.iv.B"></A>Once each quarter, the OTC derivatives dealer				must identify the number of exceptions, that is, the number of business days for				which the actual daily net trading loss, if any, exceeded the corresponding daily				VAR measure; and<br>				<br>								<LI type="A"><A NAME="e.1.iv.C"></A>An OTC derivatives dealer must use the multiplication				factor indicated in Table 1 of this Appendix F in determining its capital charge				for market risk until it obtains the next quarter's backtesting results, unless the				Commission determines that a different adjustment or other action is appropriate.<br>				<br>								<TABLE BORDER="7" WIDTH="357">					<TR>						<TD COLSPAN="2">							<P ALIGN="CENTER"><FONT SIZE="4">Table 1.--Multiplication Factor Based on Results							of Backtesting</FONT>						</TD>					</TR>					<TR>						<TD WIDTH="50%" HEIGHT="10">							<P ALIGN="CENTER">Number of exceptions						</TD>						<TD WIDTH="50%" HEIGHT="10">							<P ALIGN="CENTER">Multiplication factor						</TD>					</TR>					<TR>						<TD COLSPAN="2">							<P ALIGN="CENTER"><FONT SIZE="4">4 or fewer.........................3.00</FONT>						</TD>					</TR>					<TR>						<TD COLSPAN="2">							<P ALIGN="CENTER"><FONT SIZE="4">5.........................3.40</FONT>						</TD>					</TR>					<TR>						<TD COLSPAN="2">							<P ALIGN="CENTER"><FONT SIZE="4">6.........................3.50</FONT>						</TD>					</TR>					<TR>						<TD COLSPAN="2">							<P ALIGN="CENTER"><FONT SIZE="4">7.........................3.65</FONT>						</TD>					</TR>					<TR>						<TD COLSPAN="2">							<P ALIGN="CENTER"><FONT SIZE="4">8.........................3.75</FONT>						</TD>					</TR>					<TR>						<TD COLSPAN="2">							<P ALIGN="CENTER"><FONT SIZE="4">9.........................3.85</FONT>						</TD>					</TR>					<TR>						<TD COLSPAN="2">							<P ALIGN="CENTER"><FONT SIZE="4">10 or more.........................4.00</FONT>						</TD>					</TR>				</TABLE>			</OL>		</OL>		<br><br>				<LI type="1"><A NAME="e.2"></A>Quantitative requirements.  An OTC derivatives dealer		applying this Appendix F must have a VAR model that meets the following minimum quantitative		requirements:<br>		<br>				<OL Type="i">			<LI type="i"><A NAME="e.2.i"></A>The VAR measures must be calculated on a daily basis			using a 99 percent, one-tailed confidence level with a price change equivalent to			a ten-business day movement in rates and prices;<br>			<br>						<LI type="i"><A NAME="e.2.ii"></A>The effective historical observation period for			VAR measures must be at least one year, and the weighted average time lag of the			individual observations cannot be less than six months.  Historical data sets must			be updated at least every three months and reassessed whenever market prices or volatilities			are subject to large changes;<br>			<br>						<LI type="i"><A NAME="e.2.iii"></A>The VAR measures must include the risks arising			from the non-linear price characteristics of options positions and the sensitivity			of the market value of the positions to changes in the volatility of the underlying			rates or prices.  An OTC derivatives dealer must measure the volatility of options			positions by different maturities;<br>			<br>						<LI type="i"><A NAME="e.2.iv"></A>The VAR measures may incorporate empirical correlations			within and across risk categories, provided that the OTC derivatives dealer has described			its process for measuring correlations in its application to apply this Appendix			F and the Commission has approved its application.  In the event that the VAR measures			do not incorporate empirical correlations across risk categories, the OTC derivatives			dealer must add the separate VAR measures for the four major risk categories in paragraph			(e)(2)(v) of this Appendix F to determine its aggregate VAR measure; and<br>			<br>						<LI type="i"><A NAME="e.2.v"></A>The OTC derivatives dealer's VAR model must use			risk factors sufficient to measure the market risk inherent in all covered positions.			 The risk factors must address, at a minimum, the following major risk categories:			interest rate risk, equity price risk, foreign exchange rate risk, and commodity			price risk. For material exposures in the major currencies and markets, modeling			techniques must capture, at a minimum, spread risk and must incorporate enough segments			of the yield curve to capture differences in volatility and less-than-perfect correlation			of rates along the yield curve.  An OTC derivatives dealer must provide the Commission			with evidence that the OTC derivatives dealer's VAR model takes account of specific			risk in positions, including specific equity risk, if the OTC derivatives dealer			intends to utilize its VAR model to compute capital charges for equity price risk.<br>			<br>					</OL>	</OL></OL><HR><DIV ALIGN="CENTER"><H3><font color="#FC1921"><A NAME="history">Regulatory History</A></FONT></H3></DIV><br>40 FR 29799, July 16, 1975; 51 FR 41298, 1986: 52 FR 22298, 1987; 56 FR 9129, 1991; 58 FR 43559, Aug. 17, 1993; 58 FR 56984, Dec. 2, 1993; 59 FR 5945, Feb. 9, 1994; 62 FR 6474, 6480, Feb. 12, 1997; 63 FR 59362, 59397, Nov. 3, 1998<br><br><a href="#top">Return to top</a><hr><!--Sequential Linkers--><table id="seqlinker" width="100%" cellpadding="3" cellspacing="0" border="0" class="navbarbot"><tr><td align="center"><a href="rule15c3-1e.html">Previous</a><a href="reg15C.html">&nbsp;&#8226;&nbsp;Contents&nbsp;&#8226;&nbsp;</a><a href="rule15c3-1g.html">Next</a></td></tr></table><!--End Sequential Linkers--><br><table border=0 cellpadding=0 cellspacing=0 align="center" width="100%" class="main">  <tr>    <td width="8" height="8"><img src="../Images/cbox/corner_ul.gif" width="8" height="8" border="0"></td>    <td width="100%" height="8" background="../Images/cbox/box_top.gif"><img src="../Images/cbox/box_top.gif" width="10" height="8" border="0"></td>    <td width="8" height="8"><img src="../Images/cbox/corner_ur.gif" width="8" height="8" border="0"></td>  </tr>  <tr valign="top">    <td width="8" height="100%" background="../Images/cbox/box_left.gif"><img src="../Images/cbox/box_left.gif" height="10" width="8" border="0"></td>    <td width="100%" align="left" valign="middle">            <table width="100%" cellpadding="8" cellspacing="0" border="0" align="center" valign="top">        <tr>          <td class="small">            <p><strong>Notice to Users:</strong> The Deskbook is made available              with the understanding that the University of Cincinnati College              of Law is not engaged in rendering legal, accounting or other professional              services. If legal advice or other expert assistance is required,              the services of a competent professional person should be sought. See <a href="../index.html">Terms  and Conditions of Use</a>. &nbsp;<img src="../images/ingotxsm.gif" alt="UC Brand Ingot" width="12" height="3"></p></td>        </tr>        <tr> <td class="small"><div align="center">&copy; Copyright 1998-2009,              University of Cincinnati, All Rights Reserved <br>&nbsp;Contact: <a class="nav" href="mailto:ronald.jones@uc.edu">ronald.jones@uc.edu</a> </div>          </td>        </tr>      </table></td>    <td width="8" height="100%" background="../Images/cbox/box_right.gif"><img src="../Images/cbox/box_right.gif" height="10" width="8" border="0"></td>  </tr>  <tr>    <td width="8" height="8"><img src="../Images/cbox/corner_ll.gif" width="8" height="8" border="0"></td>    <td width="100%" height="8" background="../Images/cbox/box_bot.gif"><img src="../Images/cbox/box_bot.gif" width="10" height="8" border="0"></td>    <td width="8" height="8"><img src="../Images/cbox/corner_lr.gif" width="8" height="8" border="0"></td>  </tr></table></body></html>